Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis.

Ferreira, Thais B

Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis. [electronic resource] - Immunology Dec 2014 - 560-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2567

10.1111/imm.12334 doi


Adrenal Cortex Hormones--metabolism
Adult
Cytokines--biosynthesis
Drug Resistance
Female
Humans
Interleukin-17--biosynthesis
Interleukin-6--metabolism
Lymphocyte Activation--drug effects
Male
Multiple Sclerosis--immunology
Multiple Sclerosis, Relapsing-Remitting--immunology
Receptors, Interleukin-6--metabolism
Signal Transduction
T-Lymphocyte Subsets--drug effects
Th17 Cells--immunology
Young Adult